SE316136B - - Google Patents
Info
- Publication number
- SE316136B SE316136B SE15830/65A SE1583065A SE316136B SE 316136 B SE316136 B SE 316136B SE 15830/65 A SE15830/65 A SE 15830/65A SE 1583065 A SE1583065 A SE 1583065A SE 316136 B SE316136 B SE 316136B
- Authority
- SE
- Sweden
- Prior art keywords
- alkoxy
- compound
- water
- milk
- antiprotozoal
- Prior art date
Links
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 abstract 2
- 230000001476 alcoholic effect Effects 0.000 abstract 2
- 230000000842 anti-protozoal effect Effects 0.000 abstract 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 2
- 239000003904 antiprotozoal agent Substances 0.000 abstract 2
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 238000000605 extraction Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical class C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 1
- 235000017060 Arachis glabrata Nutrition 0.000 abstract 1
- 244000105624 Arachis hypogaea Species 0.000 abstract 1
- 235000010777 Arachis hypogaea Nutrition 0.000 abstract 1
- 235000018262 Arachis monticola Nutrition 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 108010028690 Fish Proteins Proteins 0.000 abstract 1
- 108010058643 Fungal Proteins Proteins 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 241000187747 Streptomyces Species 0.000 abstract 1
- 230000000507 anthelmentic effect Effects 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 235000020232 peanut Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 235000008476 powdered milk Nutrition 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 235000020183 skimmed milk Nutrition 0.000 abstract 1
- 150000005846 sugar alcohols Polymers 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US416599A US3361742A (en) | 1964-12-07 | 1964-12-07 | 5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE316136B true SE316136B (de) | 1969-10-20 |
Family
ID=23650586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE15830/65A SE316136B (de) | 1964-12-07 | 1965-12-07 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3361742A (de) |
| AT (1) | AT269350B (de) |
| BE (1) | BE673376A (de) |
| BR (1) | BR6575537D0 (de) |
| CH (1) | CH475997A (de) |
| DE (1) | DE1467872A1 (de) |
| ES (1) | ES320436A1 (de) |
| FR (1) | FR1553664A (de) |
| GB (1) | GB1092888A (de) |
| NL (1) | NL6515880A (de) |
| SE (1) | SE316136B (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3523941A (en) * | 1967-03-06 | 1970-08-11 | Hoffmann La Roche | Benzodiazepine compounds and process for their preparation |
| US3524849A (en) * | 1967-10-27 | 1970-08-18 | Hoffmann La Roche | Process for the preparation of pyrrolo-benzodiazepine acrylamides and intermediates useful therein |
| DE1965304A1 (de) * | 1968-12-30 | 1970-07-23 | Fujisawa Pharmaceutical Co | Benzdiazepinon-Verbindungen und Verfahren zu ihrer Herstellung |
| JPS5279082A (en) * | 1975-12-25 | 1977-07-02 | Green Cross Corp:The | Preparation of anti-tumor compound |
| JPS585916B2 (ja) | 1977-12-27 | 1983-02-02 | 株式会社ミドリ十字 | 新規ベンゾジアゼピン系化合物 |
| CA1214774A (en) * | 1983-02-10 | 1986-12-02 | Yusei Shiraga | Benzodiazepine derivative |
| AUPO470197A0 (en) * | 1997-01-21 | 1997-02-13 | Attfield, Paul Victor | Fluorescent dyes from microorganisms |
| MX368648B (es) | 2010-04-15 | 2019-10-09 | Seattle Genetics Inc | Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas. |
| CN103068405A (zh) | 2010-04-15 | 2013-04-24 | 西雅图基因公司 | 靶向吡咯并苯并二氮杂卓结合物 |
| US9399641B2 (en) | 2011-09-20 | 2016-07-26 | Medimmune Limited | Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates |
| CA2850264C (en) | 2011-10-14 | 2019-11-05 | Medimmune Limited | Pyrrolobenzodiazepines |
| CA2850373C (en) | 2011-10-14 | 2019-07-16 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| AU2012322934B2 (en) | 2011-10-14 | 2016-09-08 | Medimmune Limited | Pyrrolobenzodiazepines |
| CA2850375C (en) | 2011-10-14 | 2019-07-02 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| PT2906248T (pt) | 2012-10-12 | 2019-03-04 | Medimmune Ltd | Pirrolobenzodiazepinas e conjugados das mesmas |
| BR112015008238A2 (pt) | 2012-10-12 | 2017-11-28 | Adc Therapeutics Sarl | conjugados de pirrolbenzodiazepina-anticorpo anti-cd22 |
| DK2839860T3 (da) | 2012-10-12 | 2019-06-17 | Medimmune Ltd | Pyrrolobenzodiazepiner og konjugater deraf |
| WO2014057114A1 (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sàrl | Pyrrolobenzodiazepine-anti-psma antibody conjugates |
| KR101995620B1 (ko) | 2012-10-12 | 2019-07-03 | 에이디씨 테라퓨틱스 에스에이 | 피롤로벤조디아제핀-항체 컨주게이트 |
| PT2906253T (pt) | 2012-10-12 | 2018-11-05 | Medimmune Ltd | Conjugados de anticorpo anti-psma de pirrolobenzodiazepina |
| DK2906298T3 (en) | 2012-10-12 | 2018-12-17 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| EP2906249B1 (de) | 2012-10-12 | 2018-06-27 | MedImmune Limited | Synthese und zwischenprodukte pyrrolobenzodiazepinderivaten zur konjugation |
| EP2906297B1 (de) | 2012-10-12 | 2017-12-06 | ADC Therapeutics SA | Pyrrolobenzodiazepin-antikörper-konjugate |
| US10010624B2 (en) | 2013-10-11 | 2018-07-03 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| WO2015052534A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| CN107148285B (zh) | 2014-11-25 | 2022-01-04 | Adc治疗股份有限公司 | 吡咯并苯并二氮杂䓬-抗体缀合物 |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| RS61795B1 (sr) | 2017-02-08 | 2021-06-30 | Adc Therapeutics Sa | Konjugati pirolobenzodiazepin antitela |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| SMT202200490T1 (it) | 2017-04-18 | 2023-01-13 | Medimmune Ltd | Coniugati di pirrolobenzodiazepina |
| WO2018193102A1 (en) | 2017-04-20 | 2018-10-25 | Adc Therapeutics Sa | Combination therapy with an anti-axl antibody-drug conjugate |
| KR102442736B1 (ko) | 2017-06-14 | 2022-09-16 | 에이디씨 테라퓨틱스 에스에이 | 항-cd19 adc의 투여를 위한 투약량 체제 |
| SI3668874T1 (sl) | 2017-08-18 | 2022-04-29 | Medimmune Limited | Pirolobenzodiazepinski konjugati |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| CN113631560B (zh) | 2019-03-15 | 2025-02-18 | 麦迪穆有限责任公司 | 氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3247187A (en) * | 1963-07-10 | 1966-04-19 | Hoffmann La Roche | Oxidation of 1, 4-benzodiazepines to 1, 4-benzodiazepin-2-ones |
-
1964
- 1964-12-07 US US416599A patent/US3361742A/en not_active Expired - Lifetime
-
1965
- 1965-12-03 FR FR1553664D patent/FR1553664A/fr not_active Expired
- 1965-12-04 DE DE19651467872 patent/DE1467872A1/de active Pending
- 1965-12-06 GB GB51119/65A patent/GB1092888A/en not_active Expired
- 1965-12-06 ES ES0320436A patent/ES320436A1/es not_active Expired
- 1965-12-06 AT AT1097465A patent/AT269350B/de active
- 1965-12-07 CH CH1683365A patent/CH475997A/de not_active IP Right Cessation
- 1965-12-07 NL NL6515880A patent/NL6515880A/xx unknown
- 1965-12-07 BE BE673376D patent/BE673376A/xx unknown
- 1965-12-07 BR BR175537/65A patent/BR6575537D0/pt unknown
- 1965-12-07 SE SE15830/65A patent/SE316136B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US3361742A (en) | 1968-01-02 |
| DE1467872A1 (de) | 1969-05-14 |
| NL6515880A (de) | 1966-06-08 |
| BE673376A (de) | 1966-04-01 |
| AT269350B (de) | 1969-03-10 |
| CH475997A (de) | 1969-07-31 |
| FR1553664A (de) | 1969-01-17 |
| GB1092888A (en) | 1967-11-29 |
| BR6575537D0 (pt) | 1973-09-06 |
| ES320436A1 (es) | 1966-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1092888A (en) | Antibiotic substances and process for the manufacture thereof | |
| Lee et al. | Calichemicins, a novel family of antitumor antibiotics. 2. Chemistry and structure of calichemicin. gamma. 1I | |
| SE7703592L (sv) | Anthelmintikum | |
| BRPI0519624B1 (pt) | processo para preparação de ansamitocinas purificadas | |
| Argoudelis et al. | MICROBIAL TRANSFORMATION OF ANTIBIOTICS. I PRODUCTION OF LINCOMYCIN SULFOXIDE AND 1-DEMETHYLTHIO-1-HYDROXYLINCOMYCIN BY S. LINCOLNENSIS | |
| ISSHIKI et al. | The structure of a new antibiotic, terpentecin | |
| IE35575L (en) | Anthelmintics; amidophenoxy ethers | |
| GB1349179A (en) | Antibiotic | |
| JPS5842869B2 (ja) | ホモセリンラクトン誘導体 | |
| IL42685A (en) | Antibiotic a-2315 and process for preparation thereof | |
| GB1226494A (de) | ||
| GB1126214A (en) | Antiamoebin, a new antiprotozoal and anthelmintic antibiotic, and a method of producing the same | |
| US4091093A (en) | Protease inhibitors | |
| GB1116280A (en) | Antibiotic a28829 | |
| Vining et al. | Separation of endomycins A and B, and their identification as members of the polyene groups of antifungal antibiotics | |
| KR920002795A (ko) | 항생제 발히마이신, 이의 제조방법 및 약제로서 이의 용도 | |
| KR920009986A (ko) | 다이네마이신 c 항종양 항생제 | |
| Puar et al. | The biosynthesis of AR-5 (mycinamicins) antibiotics | |
| GB1220017A (en) | Antibiotic substances related to daunomycin | |
| GB1157998A (en) | Antibiotic SL 1846 | |
| GB1356723A (en) | Antibiotic sf-1293 substance and its production and uses | |
| GB912339A (en) | Process for the manufacture of the antibiotic pilosomycin, its components and salts thereof | |
| Sheiman et al. | Syntheses of di-and tetrahydropyrroles | |
| Lam et al. | Serratiomycin, a new antibacterial peptolide from an eubacterium culture, MB 5691 | |
| Sheiman et al. | Syntheses of di-and tetrahydropyrroles: X. Synthesis of 3, 3-dimethyl-2-methylene-5-pyrrolidone and its derivatives. investigation of the electrophilic addition of alcohols and water to them |